FDA Panel Recommends Pulling Preterm Birth Drug From the Market In use for 11 years, the drug Makena provided a [...] By digitalstudios|2022-10-19T19:50:02+00:00October 19, 2022|3rd Party Pharmaceutical Industry News|Comments Off on FDA Panel Recommends Pulling Preterm Birth Drug From the Market Read More
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science? The agency’s accelerated approval program for certain drugs has come [...] By digitalstudios|2022-03-25T15:15:07+00:00March 25, 2022|3rd Party Pharmaceutical Industry News|Comments Off on F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science? Read More